Feature | Clinical Decision Support | January 18, 2018

National Decision Support Company Acquired by Change Healthcare

Purchase will help bring clinical intelligence to the point of care, meet healthcare reform guidelines

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader in cloud-based clinical decision support (CDS) software that delivers medical guidelines to the point of care in electronic medical record (EMR) systems. The addition of NDSC accelerates the efforts of Change Healthcare to leverage evidence-based clinical information and next-generation technologies to help reduce healthcare costs and ensure appropriate care.

"We are singularly focused on helping customers address the big challenges in healthcare—achieving better outcomes, reducing costs, and creating an interconnected healthcare ecosystem. With NDSC, we've added strategic capabilities to accelerate our product roadmap and increase the value we provide to healthcare stakeholders," said Neil de Crescenzo, president and chief executive officer (CEO), Change Healthcare. "NDSC puts clinical intelligence in the hands of physicians and other clinicians as they are delivering care. With ready access to medical guidelines, clinicians can make decisions that lead to better patient outcomes, improve efficiency, and optimize care paths based on world-class clinical expertise."

NDSC's flagship offering, CareSelect Imaging, delivers evidence-based guidelines for medical imaging through an exclusive digital distribution license with the American College of Radiology (ACR). This relationship also puts the company in a position to help customers meet federal healthcare reform mandates requiring that clinicians consult appropriate use criteria (AUC) for imaging. 

NDSC's current portfolio also includes CareSelect Choosing Wisely, founded on the American Board of Internal Medicine's Choosing Wisely Initiative, and CareSelect Lab, based on a partnership with the Mayo Clinic. With a rapidly growing customer base of more than 500 provider organizations, NDSC is a proven technology platform for the delivery of guidance at the point of order.

NDSC and the Change Healthcare InterQual team have used the NDSC platform to deliver industry leading clinical criteria to the point of care, leveraging real-time access to clinical data. The goal of this relationship is to streamline utilization management and authorization processes, which today are labor-intensive, redundant, and expensive.

"We have forged a strong and complementary working relationship across our teams with a special, rarely attained energy," said Michael Mardini, CEO, NDSC, who will continue leading the NDSC team within Change Healthcare as part of the company's decision support portfolio. "We share a vision and passion for improving care delivery through innovative technology and common-sense process improvements. This strategic and cultural fit will accelerate the success of our combined organizations, and it expands our ability to deliver solutions that improve patient care and decrease cost across the payer and provider ecosystem."

The NDSC team will continue to operate from its offices in Madison, Wis. The NDSC acquisition also accelerates the expansion of Change Healthcare's operations in Madison through the planned addition of other company operations there.

Change Healthcare leverages software, analytics, network solutions and technology-enabled services to enable better patient care through EMRs. Change acquired McKesson’s information technology division, including cardiology and radiology IT solutions, in 2017.  

For more information: www.changehealthcare.com

Related Content

FDA Releases Final Rule on Data Acceptance from Medical Device Clinical Investigations
News | Business | February 21, 2018
The U.S. Food and Drug Administration (FDA) issued the final rule on “Human Subject Protection; Acceptance of Data from...
Amazon, Berkshire Hathaway and JPMorgan Chase to Form New Healthcare Company
News | Business | January 30, 2018
January 30, 2018 — Amazon , Berkshire Hathaway and JPMorgan Chase & Co.
News | Business | January 16, 2018
American College of Cardiology (ACC) Chief Executive Officer Shalom “Shal” Jacobovitz will be leaving the College...
CMS Launches New Voluntary Bundled Payments Model
News | Business | January 10, 2018
The Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (Innovation Center)...
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
January 8, 2018 — Canon Inc. and Canon Medical Systems Corp.
CMS Announces Final Changes, Cancellations of Mandatory Bundled Payment Models
News | Business | December 21, 2017
The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the mandatory hip...
Catheter reprocessing can reduce costs in the cath and EP lab.
Feature | Business | December 19, 2017 | Lars Thording
As payers and other healthcare entities look to better manage costs, especially in the acute care setting, it is impo
FDA Issues Final Guidance on Investigational Device Exemption Categorization
News | Business | December 19, 2017
The U.S. Food and Drug Administration (FDA) recently issued a final guidance, “FDA Categorization of Investigational...
Congressional Budget Office Finds cutting ACA insurance mandate will cause 13 million people to become uninsured, higher insurance premiums. American Heart Association (AHA), #AHA2017
News | Business | December 06, 2017
December 6, 2017 — At the American Heart Association (AHA) annual meeting in November, a group of 16 non-partisan pat
5 Tips for Medical Device Engineers on FDA Design Controls
Feature | Business | November 24, 2017 | Jon Speer
If you are an engineer in the medical device industry, you probably have a love/hate relationship with the FDA-mandat
Overlay Init